Let Science help you lose weight, and make you look fit and slim

Did you know it’s possible to shed up to 21% of your body weight in just 16 months—without hunger, calorie tracking, or spending hours at the gym?

Our Simple, Smart & Science-Backed Plan:

Why Our Program Works:

weight management in pune

Weight loss is 80% diet and 20% exercise. Many people struggle to stay consistent—but our Wegovy/ Mounjaro Weight Loss Treatment in Pune makes it easier than ever to stay on track. 

Good news: our treatment tells your brain you’re full.

Fat loss and fitness improvement visual holding fatnil package

This clinically proven medication helps you feel full faster, making portion control and appetite management effortless.

Clinical studies show our approach can help you lose up to 5 times more weight than diet and exercise alone.

A 2022 clinical trial with 2,539 adults showed participants achieved up to 21% weight loss in 16 months, compared to placebo. Our Wegovy/ Mounjaro Weight Loss Clinic in India uses that same scientific approach—delivering real, measurable outcomes.

Clinically proven Non-Surgical Obesity Treatment in Pune up to achieve 21% weight loss in 16 months. Wondering how much you could lose?

BMI Calculator

How much weight you can loose in our FatNil program

Weight Loss Calculator
Your weight in 6 months: ?
Your weight in 16 months: ?
Weight Loss News Slider

The breakthrough in weight loss medication has hit the news big time.

  • Ground-breaking weight loss injection gets approved in India

  • Revolutionary weight loss injection hits India; good news for obese people

  • Hansal Mehta praises newly-launched weight loss injection

  • Has this injection finally cracked the weight loss code?

  • Weight loss injection launches in India: Is it the answer to obesity?

    Simple, science-backed, and effective. Our weight loss program succeeds where others fall short.

    I enjoy food too much to stick to a strict diet.

    If you can do light exercise, such as walking for 30 minutes a few times a week, that’s all it takes!

    Staying motivated can feel challenging.

    Our injection removes the difficulty of adhering to a diet, and our team is always here to support you.

    I just don’t have time for regular exercise.

    If you can walk or do light exercise for 30 minutes a few times a week, that’s enough!

    Common Concerns We Solve

    If you love food, the treatment helps you feel full with less. Even without heavy exercise, light 30-minute walks are enough. 

    What makes this weight loss plan unique?

    Our programs follow clinically proven, doctor-endorsed treatment protocols. Each plan is personalized and science-based to suit individual needs. 

    Why Choose FatNil weight loss in Pune?

    Our Non-Surgical Obesity Treatment Pune stands out with doctor-endorsed protocols, personalized Wegovy /Mounjaro Injection Consultation India plans, and rapid delivery of first-month supplies.

    Ready to start losing weight and feeling fit? Take your first step now:

    Answer a few medical questions to see if our treatment is safe for you.

    Based on your results, we create a personalised Fatnil programme for you.

    If the doctor approves you for treatment, you will receive your injections’ first month’s supply in a few days.

    Your first step towards better health, more energy, and boosting your self-esteem.

    Disclaimer and sources

    Our treatment should be taken alongside a healthy diet and lifestyle. Because everybody is different, individual results vary and depend on lifestyle.

    The information on our website is based on clinical results. You can read the studies below. Because everybody is different, individual results vary and depend on lifestyle.

    [1] Diet Failure Statistics 2023 | Why Do Diets Fail? Source: The Journal of Clinical Nutrition.[2] Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., & Stefanski, A. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/nejmoa2206038